Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

NCT01368757 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.

NCT NCT01368757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01368757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Lead sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2010
Completion date
May 31, 2015
Enrollment
30 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelomonocytic leukemia